Ocular Therapeutix Stock (NASDAQ:OCUL), Quotes and News Summary

Q: What sector and industry does Ocular Therapeutix (OCUL) operate in?

Ocular Therapeutix is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Ocular Therapeutix Stock (NASDAQ: OCUL) stock price, news, charts, stock research, profile.

Open	$7.600
Close	$5.860
Volume / Avg.	6.071M / 2.061M
Day Range	5.850 - 7.610
52 Wk Range	1.995 - 11.310
Market Cap	$869.471M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	22
Short Interest	8.31%
Days to Cover	8.06

Recent News

Ocular Therapeutix Highlights Early Data From Diabetes-Related Eye Disorder

Ocular Therapeutix's Phase 1 HELIOS study unveils Axpaxli's efficacy in treating non-proliferative diabetic retinopathy. Significant DRSS improvement with no worsening observed. Positive Phase 2 data for Paxtrava also disclosed, showing substantial reduction in intraocular pressure.

Vandana Singh

Why Las Vegas Sands Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

Avi Kapoor

Why Asana Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

Shares of Asana, Inc. (NYSE: ASAN) fell sharply during Tuesday’s session following soft FY25 revenue guidance.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trend

Feb

Mar

Apr

Buy

Hold

Sell

Strong Sell

Analyst Rating

3.9

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

About Ocular Therapeutix Inc

Sector

Health Care

Industry

Pharmaceuticals

Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and con...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Ocular Therapeutix (OCUL) stock?

You can purchase shares of Ocular Therapeutix (NASDAQ: OCUL) through any online brokerage.

View our list of the best stock brokerages.

Who are Ocular Therapeutix's (OCUL) competitors?

Other companies in Ocular Therapeutix’s space includes: Supernus Pharmaceuticals (NASDAQ:SUPN), Verona Pharma (NASDAQ:VRNA), WAVE Life Sciences (NASDAQ:WVE), Tarsus Pharmaceuticals (NASDAQ:TARS) and Neumora Therapeutics (NASDAQ:NMRA).

What is the target price for Ocular Therapeutix (OCUL) stock?

The latest price target for Ocular Therapeutix (NASDAQ: OCUL) was reported by JMP Securities on Tuesday, April 16, 2024. The analyst firm set a price target for 24.00 expecting OCUL to rise to within 12 months (a possible 310.26% upside). 17 analyst firms have reported ratings in the last year.

Current Stock Price for Ocular Therapeutix (OCUL)?

The stock price for Ocular Therapeutix (NASDAQ: OCUL) is $5.85 last updated Today at April 18, 2024 at 5:54 PM EDT.

Does Ocular Therapeutix (OCUL) pay a dividend?

There are no upcoming dividends for Ocular Therapeutix.

When is Ocular Therapeutix (NASDAQ:OCUL) reporting earnings?

Ocular Therapeutix’s Q1 earnings are confirmed for Monday, May 6, 2024.

Is Ocular Therapeutix (OCUL) going to split?

There is no upcoming split for Ocular Therapeutix.

What sector and industry does Ocular Therapeutix (OCUL) operate in?

Ocular Therapeutix is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-